Perhaps,
Hydroxychloroquine
improves
COVID-19
(BioMindmap Proof Quality is Low.)
Perhaps,
Hydroxychloroquine
improves
COVID-19
(BioMindmap Proof Quality is Low.)
1.9
ValidityScore
Valid or Invalid?
-
2020Systematic Review
-
Gomes TF, Gonçalves GL, Guimarães VR, Leite KR, Pimenta R, Reis ST, Sro M, Sro V, Viana NI -
«Results : Among 214 studies that were found, 3 were included for in the meta‐ analysis. Patients treated with HCQ had a faster clearance of virus or pneumonia improvement than those that received standard treatment (OR = 7.08, 95% CI 2.79 to 4.12; P = 0.001). Only minor side effects were reported. Conclusions : Although this meta-analysis has found favorable evidence for the use of HCQ in the treatment of COVID-19, the literature does not yet present well-designed clinical studies that demonstrate the effectiveness of this medication. We believe that clinical trials coordinated by standardized guidelines, with complete and quality information, must be carried out worldwide and are urgently needed.»
- Organism: Humans
- Notable Magnitude of Effect.
-
#Europe PMC, Europe PubMed Central, ORCIDs, REST APIs, abstracts, bioinformatics, biological patents, biomedical journals, biomedical research, citation networks, citation search, clinical guidelines, full text, journal articles, life sciences, literature search, open access, research articles, text miningmore... -
Proofless opinion
of
ranked
who
added it
2 years ago
on Jun 7, 2020